Access Free T3
The Access Free T3 assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of free triiodothyronine levels in human serum and plasma using the…
The Access Free T3 assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of free triiodothyronine levels in human serum and plasma using the Access Immunoassay Systems.
Who Else Makes It
Concentrated in Jilin (1), Hebei (1), Guangdong (1).
| Manufacturer | City | Province | Registered as | Device types |
|---|---|---|---|---|
| Dirui Industrial Co., Ltd. | Changchun | Jilin | Contract manufacturer | 84 |
| Shijiazhuang Hipro Biotechnology Co., Ltd. | Shijiazhuang | Hebei | Manufacturer | 22 |
| Shenzhen Yhlo Biotech Co., Ltd. | Shenzhen | Guangdong | Manufacturer | 19 |
| Getein Biotech, Inc. | Nanjing | Jiangsu | Manufacturer | 19 |
| Beijing Hotgen Biotech Co., Ltd. | Beijing | Beijing | Manufacturer | 13 |
Record
| Listed by | Beckman Coulter, Inc., United States |
|---|---|
| FDA product code | CDP |
| Device type | Radioimmunoassay, Total Triiodothyronine |
| Device class | Class 2 |
| Regulation | 21 CFR 862.1710 |
| Establishment | Contract manufacturer, Specification developer, Manufacturer, Exporter |
| Premarket notification | Exempt |
| Record published | 2023-06-26 |
Specifications
| MRI safety | Labeling does not contain MRI Safety Information |
|---|---|
| Prescription | Prescription only |
| Supplied as a kit | Yes |
| Label carries | lot or batch number, expiry date, manufacturing date |
Catalogue Numbers
| Catalogue number | Size | Status |
|---|---|---|
| A13422 | In distribution |
Same Product Code
| Product | Sold by | Catalogue numbers |
|---|---|---|
| Architect | Abbott Ireland | 9 |
| Alinity | Abbott Ireland | 5 |
| Elecsys FT3 III | Roche Diagnostics Gmbh | 4 |
| Elecsys T3 | Roche Diagnostics Gmbh | 4 |
| Advia Centaur® T3 | Siemens Healthcare Diagnostics Inc | 3 |
| Free Triiodothyronine (fT3) Elisa | DRG Instruments Gesellschaft mit beschränkter Haftung | 3 |
| Total T3 125I RIA Kit | Mp Biomedicals, LLC | 3 |
| Atellica IM FT3 | Siemens Healthcare Diagnostics Inc | 3 |
| Vitros | Ortho-Clinical Diagnostics, Inc. | 3 |
| Atellica IM T3 | Siemens Healthcare Diagnostics Inc | 3 |
| Advia Centaur® FT3 | Siemens Healthcare Diagnostics Inc | 3 |
| Free Triiodothyronine (fT3) Elisa | DRG International, Inc. | 3 |
Showing 12 of 78. All products under Radioimmunoassay, Total Triiodothyronine
Recalls Naming This Product
1 recall names this product by its own identifier, the UDI on its label.
| Recalled by | Identified by | Initiated | FDA class | Root cause | Reason | Quantity |
|---|---|---|---|---|---|---|
| Beckman Coulter, Inc. | UDI-DI | 2023-03-15 | Class II | Process design | The reagent lot produces elevated results (approximately >30%) in some (15-20%)patient samples that do not correlate with the results of other thyroid markers nor Free T3 results generated on other platforms. This introduces a risk of the p | 31,076 units |
Recalls
5 of these are Class II. Class II means a temporary or reversible health consequence. Class III is unlikely to cause harm at all → typically a labelling or documentation fault. Volume alone is not a quality signal: a manufacturer that ships more recalls more.
| Initiated | FDA class | Root cause | Reason | Quantity | Closed |
|---|---|---|---|---|---|
| 2019-04-30 | Class II | Other | The recalling firm characterized the potential interference effects of biotin (up to 1,200 ng/mL) on all biotin-mediated Access assays. The following six assays: Free T3-REF A13422, Total T3-REF 33830, Free T4-REF 33880, GI Mon-387687, Tg-R | 238,862 | 2021-12-28 |
| 2019-04-30 | Class II | Other | The recalling firm characterized the potential interference effects of biotin (up to 1,200 ng/mL) on all biotin-mediated Access assays. The following six assays: Free T3-REF A13422, Total T3-REF 33830, Free T4-REF 33880, GI Mon-387687, Tg-R | 418,400 units | 2021-12-28 |
| 2017-05-09 | Class II | Device Design | The Access immunoassays are susceptible to biotin interference. | 313,158 units total (43,725 units in US) | 2018-03-30 |
| 2016-06-08 | Class II | Device Design | Demonstrate an upward shift in patient results. | 205,744 kits total (13,358 kits in US) | 2017-04-18 |
| 2015-08-31 | Class II | Under Investigation by firm | Beckman Coulter, Inc. is recalling Access Free T3 Reagent Kit because they were filled incorrectly and contain insufficient quantity of reagents in one or more of the pack wells. | 16,648 units total (1874 units in US) | 2016-05-16 |
| 2011-10-11 | Class III | Device Design | A recall was initiated because Beckman Coulter has identified a negative bias in test results when comparing elevated Total T3 patient samples diluted with Sample Diluent A to samples diluted with Access Total T3 Calibrator S0. | 117,385 units total (33,918 units in US) | 2013-03-14 |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.